Accessibility Menu
Elevance Health logo

Elevance Health(NYSE) ELV

Market Cap$81.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2001)+2,266%
5 Year+8%
1 Year+40%
1 Month-10%
$377.59
-1.35%
-5.18Today
Elevance Health last closing stock price
MetricPriceDate
Last closeUSD 378.002026-08-04
Elevance Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2%USD 385.732026-07-28
1 month-9.55%USD 417.892026-07-02
3 month+1.29%USD 373.192026-05-06
Year to date+8.94%USD 346.992025-12-31
1 year+40.38%USD 269.272025-08-04
3 year-14.28%USD 440.982023-08-04
5 year+7.82%USD 350.572021-08-05
Since inception+2,266.39%USD 16.182001-10-30

Elevance Health Financials at a Glance

Market Cap

$81.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$201.11B

Net Income (TTM)

$4.96B

EPS (TTM)

$22.50

P/E Ratio

16.80

Dividend

$6.86

Beta (Volatility)

0.44 (Low)

Price

$377.59

Volume

220.456

Open

$381.02

Previous Close

$378.00

Daily Range

$376.38 - $382.74

52-Week Range

$273.71 - $436.24

Estimated Earnings Date

Oct 21, 2026

ELV: Motley Fool Moneyball Superscore

63

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elevance Health

Elevance Health helps people get medical care and insurance. It makes paying for doctor visits and medicine simpler. The company manages health plans for millions of people.

Helping People Stay Healthy

  • Health Benefits: Provides medical, dental, and vision insurance plans to individuals and employers; generated $85.2 billion in operating revenue for the six-month period ended June 30, 2026.
  • CarelonRx: Manages pharmacy services including home delivery, specialty drugs, and claims processing; accounted for $21.9 billion in operating revenue for the first half of 2026.
  • Carelon Services: Offers specialized healthcare solutions like behavioral health and risk-based care; reported $15.3 billion in operating revenue for the six months ended June 30, 2026.

Expanding the Care Network

  • Launched the Transformation Program in early 2026 to simplify the organization and use artificial intelligence.
  • Entered new insurance markets in Florida, Maryland, and Texas during 2025.
  • Expanded healthcare operations into Washington state in 2026 using the Wellpoint brand.
  • Secured final court approval in August 2025 for a settlement agreement involving provider lawsuits.

A Giant With Deep Roots

Elevance Health operates as a major licensee of the Blue Cross and Blue Shield Association across 14 states. This partnership allows the company to use recognized brands while managing care for nearly 45 million medical members.

Measuring the Financial Health

  • Total operating revenue rose 1.2% year over year to $99.3 billion for the six months ended June 30, 2026.
  • Shareholders' net income was $3.2 billion for the first half of 2026, a decrease of 17.8% from the previous year.
  • The benefit expense ratio, which measures care costs against premiums, reached 88.3% for the six months ended June 30, 2026.
  • Net cash from operating activities increased to $6.2 billion for the six months ended June 30, 2026, up from $3.1 billion in 2025.
  • Medical membership totaled 44.9 million as of June 30, 2026, which was a 1.5% decline from the prior year.

The Path Ahead

Elevance Health has shifted from a traditional insurer to a broader health company with expanded pharmacy and clinical services. Its focus on technology and data helps it manage medical costs while serving a diverse membership base.

AI Generated • Jul 16, 2026

Industry

Healthcare Providers and Services

Employees

97,100

CEO

Gail Koziara Boudreaux, MBA

Headquarters

Indianapolis, IN 46204, US

ELV Financials

Key Financial Metrics (TTM)

Gross Margin

38.95%

Operating Margin

3.51%

Net Income Margin

2.47%

Return on Equity

11.24%

Return on Capital

10.52%

Return on Assets

3.93%

Earnings Yield

5.95%

Dividend Yield

1.81%

Payout Ratio

30.36%

Stock Overview

Market Cap

$81.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

216.87M

Volume

220.456

Avg. Volume

1.66M

Financials (TTM)

Gross Profit

$78.34B

Operating Income

$7.06B

EBITDA

$8.01B

Operating Cash Flow

$7.46B

Capital Expenditure

-$1.18B

Free Cash Flow

$6.29B

Cash & ST Invst.

$37.51B

Total Debt

$31.04B

Elevance Health Performance Analysis

Elevance Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 156,595,000,00013.0%
20232023-12-31USD 171,340,000,0009.4%
20242024-12-31USD 176,810,000,0003.2%
20252025-12-31USD 199,125,000,00012.6%
Elevance Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.9%
Q42025-12-31-1.9%
Q12026-03-310.9%
Q22026-06-300.6%
Elevance Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 24.28-1.8%
20232023-12-31USD 25.223.9%
20242024-12-31USD 25.681.8%
20252025-12-31USD 25.21-1.8%
Elevance Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-31.1%
Q42025-12-31-53.6%
Q12026-03-31223.9%
Q22026-06-30-16.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$50.47B

+1.4%

Gross Profit

$44.98B

+244.2%

Gross Margin

89.12%

N/A

Market Cap

$81.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$844.25K

N/A

Employees

97,100

N/A

Net Income

$1.46B

-16.1%

EBITDA

$2.10B

-30.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$37.51B

+338.2%

Total Debt

$31.04B

+2.8%

Accounts Receivable

$23.39B

+46.9%

Inventory

$0.00

N/A

Long Term Debt

$30.67B

+8.8%

Short Term Debt

$375.00M

-81.3%

Return on Assets

3.93%

N/A

Return on Invested Capital

8.59%

N/A

Free Cash Flow

$1.63B

-9.0%

Operating Cash Flow

$1.91B

-6.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REGNRegeneron Pharmaceuticals, Inc.
$760.66+0.19%
CICigna Corporation
$274.05-2.84%
BDXBecton, Dickinson and Company
$170.12-0.05%
GSKGSK plc
$51.53+0.04%

Trending Stocks

Symbol / CompanyPricePrice Chg
EAElectronic Arts
$209.70-0.00%
SPCXSpace Exploration Technologies
$125.33+0.09%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$37.26-0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$8.07+0.03%

Questions About ELV

What is the current price of Elevance Health?

Elevance Health is trading at $378.00 per share.

What is the 52-week range for Elevance Health?

Over the past 52 weeks, Elevance Health has traded between $273.71 and $436.24.

How much debt does Elevance Health have?

As of the most recent reporting period, Elevance Health reported total debt of $31.04B.

How much cash does Elevance Health have on hand?

Elevance Health reported $10.23B in cash and cash equivalents in its most recent financial results.

What is Elevance Health’s dividend yield?

Elevance Health currently has a dividend yield of 1.81%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.